These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26435027)

  • 1. The role of nitric oxide donors in schizophrenia: Basic studies and clinical applications.
    Pitsikas N
    Eur J Pharmacol; 2015 Nov; 766():106-13. PubMed ID: 26435027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Nitric Oxide Synthase Inhibitors in Schizophrenia.
    Pitsikas N
    Curr Med Chem; 2016; 23(24):2692-2705. PubMed ID: 27776474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Nitric Oxide (NO) Donor Sodium Nitroprusside (SNP) and Its Potential for the Schizophrenia Therapy: Lights and Shadows.
    Zoupa E; Pitsikas N
    Molecules; 2021 May; 26(11):. PubMed ID: 34073534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of nitric oxide (NO) donors in anxiety. Lights and shadows.
    Pitsikas N
    Nitric Oxide; 2018 Jul; 77():6-11. PubMed ID: 29625171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of nitric oxide in the object recognition memory.
    Pitsikas N
    Behav Brain Res; 2015 May; 285():200-7. PubMed ID: 24933185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric Oxide (NO) Synthase Inhibitors: Potential Candidates for the Treatment of Anxiety Disorders?
    Pitsikas N
    Molecules; 2024 Mar; 29(6):. PubMed ID: 38543047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pipeline and future of drug development in schizophrenia.
    Gray JA; Roth BL
    Mol Psychiatry; 2007 Oct; 12(10):904-22. PubMed ID: 17667958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia.
    Kandratavicius L; Balista PA; Wolf DC; Abrao J; Evora PR; Rodrigues AJ; Chaves C; Maia-de-Oliveira JP; Leite JP; Dursun SM; Baker GB; Guimaraes FS; Hallak JE
    BMC Neurosci; 2015 Mar; 16():9. PubMed ID: 25887360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications for nitric oxide in halting proliferation of tumor cells.
    Reynolds MM; Witzeling SD; Damodaran VB; Medeiros TN; Knodle RD; Edwards MA; Lookian PP; Brown MA
    Biochem Biophys Res Commun; 2013 Feb; 431(4):647-51. PubMed ID: 23337501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procognitive activity of nitric oxide inhibitors and donors in animal models.
    Cieślik P; Kalinowski L; Wierońska JM
    Nitric Oxide; 2022 Feb; 119():29-40. PubMed ID: 34896554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of nitric oxide (NO) modulators in obsessive-compulsive disorder (OCD).
    Pitsikas N
    Nitric Oxide; 2023 May; 134-135():38-43. PubMed ID: 37028750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide donors: novel cancer therapeutics (review).
    Huerta S; Chilka S; Bonavida B
    Int J Oncol; 2008 Nov; 33(5):909-27. PubMed ID: 18949354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressing NADPH oxidase-dependent oxidative stress in the vasculature with nitric oxide donors.
    Selemidis S
    Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1395-401. PubMed ID: 18954334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide-releasing drugs.
    Napoli C; Ignarro LJ
    Annu Rev Pharmacol Toxicol; 2003; 43():97-123. PubMed ID: 12540742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of nitric oxide pathways: therapeutic potential in asthma and chronic obstructive pulmonary disease.
    Redington AE
    Eur J Pharmacol; 2006 Mar; 533(1-3):263-76. PubMed ID: 16466650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New nitric oxide-donating drugs for the treatment of airway diseases.
    Lagente V; Advenier C
    Curr Opin Investig Drugs; 2004 May; 5(5):537-41. PubMed ID: 15202728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium nitroprusside, a nitric oxide donor for novel treatment of schizophrenia, may also modulate dopaminergic systems.
    Maia-de-Oliveira JP; Lobão-Soares B; Baker GB; Dursun SM; Hallak JE
    Schizophr Res; 2014 Nov; 159(2-3):558-9. PubMed ID: 25223842
    [No Abstract]   [Full Text] [Related]  

  • 18. Nitric oxide pathway in hypertrophied heart: new therapeutic uses of nitric oxide donors.
    Ruiz-Hurtado G; Delgado C
    J Hypertens; 2010 Sep; 28 Suppl 1():S56-61. PubMed ID: 20823718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide: new evidence for novel therapeutic indications.
    Wimalawansa SJ
    Expert Opin Pharmacother; 2008 Aug; 9(11):1935-54. PubMed ID: 18627331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide modulates apomorphine-induced recognition memory deficits in rats.
    Gourgiotis I; Kampouri NG; Koulouri V; Lempesis IG; Prasinou MD; Georgiadou G; Pitsikas N
    Pharmacol Biochem Behav; 2012 Oct; 102(4):507-14. PubMed ID: 22735830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.